Role of the transient receptor potential (TRP) channel gene expressions and TRP melastatin (TRPM) channel gene polymorphisms in obesity-related metabolic syndrome

European Review for Medical and Pharmacological Sciences

Volumn 19, Issue 8, 2015, Pages 1388-1397

  Tabur, S ^a   Oztuzcu, S ^a   Duzen, I V ^b   Eraydin, A ^a   Eroglu, S ^a   Ozkaya, M ^a   Demiryurek A T ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b Gaziantep 25 Aralik Hospital   (Turkey)

Author keywords

Expression; Gene variants; Metabolic syndrome; Obesity; Transient receptor potential

Indexed keywords

GENOMIC DNA; MELASTATIN; MESSENGER RNA; PROTEIN MCOLN2; PROTEIN MCOLN3; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRANSIENT RECEPTOR POTENTIAL CHANNEL 1; TRANSIENT RECEPTOR POTENTIAL CHANNEL 3; TRANSIENT RECEPTOR POTENTIAL CHANNEL M2; TRANSIENT RECEPTOR POTENTIAL CHANNEL M5; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 4; VANILLOID RECEPTOR 5; VANILLOID RECEPTOR 6; TRANSIENT RECEPTOR POTENTIAL CHANNEL M; TRPM5 PROTEIN, HUMAN; TRPM8 PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS SOFTWARE; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MICROARRAY KIT; OBESITY; REAL TIME POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; TURK (PEOPLE); GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; RISK FACTOR; TURKEY;

ADULT; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; POLYMORPHISM, GENETIC; RISK FACTORS; TRANSIENT RECEPTOR POTENTIAL CHANNELS; TRPM CATION CHANNELS; TURKEY;

EID: 84942252529     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. ZALESIN KC, FRANKLIN BA, MILLER WM, PETERSON ED, MCCULLOUGH PA. Impact of obesity on cardiovascular disease. Med Clin North Am 2011; 95: 919-937.
2. GRUNDY SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol 2008; 28: 629-636.
3. KOZAN O, OGUZ A, ABACI A, EROL C, ONGEN Z, TEMIZHAN A, CELIK S. Prevalence of the metabolic syndrome among Turkish adults. Eur J Clin Nutr 2007; 61: 548-553.
4. YAZICI HU, POYRAZ F, TURFAN M, SEN N, TAVIL Y, TULMAC M, VATANKULU MA, AYGÜL N, OZDO RU I, ABACI A. The prevalence of the metabolic syndrome and its impact on the left ventricular systolic function in the patients with non-diabetic first ST elevation myocardial infarction. Eur Rev Med Pharmacol Sci 2012; 16: 90-95.
5. CHO GJ, PARK HT, SHIN JH, HUR JY, KIM YT, KIM SH, LEE KW, KIM T. Calcium intake is inversely associated with metabolic syndrome in postmenopausal women: Korea National Health and Nutrition Survey, 2001 and 2005. Menopause 2009; 16: 992-997.
6. LIU S, SONG Y, FORD ES, MANSON JE, BURING JE, RIDKER PM. Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care 2005; 28: 2926-2932.
7. RICHART T, THIJS L, NAWROT T, YU J, KUZNETSOVA T, BALKESTEIN EJ, STRUIJKER-BOUDIER HA, STAESSEN JA. The metabolic syndrome and carotid intima-media thickness in relation to the parathyroid hormone to 25-OH-D3 ratio in a general population. Am J Hypertens 2011; 24: 102-109.
8. ZEMEL MB. Calcium modulation of hypertension and obesity: mechanisms and implications. J Am Coll Nutr 2001; 20: 428S-435S.
9. MONTELL C. The TRP superfamily of cation channels. Sci STKE 2005; 2005: re3.
10. NILIUS B, OWSIANIK G, VOETS T, PETERS JA. Transient receptor potential cation channels in disease. Physiol Rev 2007; 87: 165-217.
11. BERWICK ZC, DICK GM, TUNE JD. Heart of the matter: coronary dysfunction in metabolic syndrome. J Mol Cell Cardiol 2012; 52: 848-856.
12. FORD ES, MOKDAD AH, GILES WH, BROWN DW. The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes 2003; 52: 2346-2352.
13. FURUKAWA S, FUJITA T, SHIMABUKURO M, IWAKI M, YAMADA Y, NAKAJIMA Y, NAKAYAMA O, MAKISHIMA M, MATSUDA M, SHIMOMURA I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 2004; 114: 1752-1761.
14. HOLVOET P, LEE DH, STEFFES M, GROSS M, JACOBS DR Jr. Association between circulating oxidized lowdensity lipoprotein and incidence of the metabolic syndrome. JAMA 2008; 299: 2287-2293.
15. POULSEN P, VAAG A, KYVIK K, BECK-NIELSEN H. Genetic versus environmental aetiology of the metabolic syndrome among male and female twins. Diabetologia 2001; 44: 537-543.
16. ROCHE HM, PHILLIPS C, GIBNEY MJ. The metabolic syndrome: the crossroads of diet and genetics. Proc Nutr Soc 2005; 64: 371-377.
17. ZHANG S, LIU X, YU Y, HONG X, CHRISTOFFEL KK, WANG B, TSAI HJ, LI Z, LIU X, TANG G, XING H, BRICKMAN WJ, ZIMMERMAN D, XU X, WANG X. Genetic and environmental contributions to phenotypic components of metabolic syndrome: a population-based twin study. Obesity (Silver Spring) 2009; 17: 1581-1587.
18. HENNEMAN P, AULCHENKO YS, FRANTS RR, VAN DIJK KW, OOSTRA BA, VAN DUIJN CM. Prevalence and heritability of the metabolic syndrome and its individual components in a Dutch isolate: the Erasmus Rucphen Family study. J Med Genet 2008; 45: 572-577.
19. BELLIA A, GIARDINA E, LAURO D, TESAURO M, DI FEDE G, CUSUMANO G, FEDERICI M, RINI GB, NOVELLI G, LAURO R, SBRACCIA P. "The Linosa Study": epidemiological and heritability data of the metabolic syndrome in a Caucasian genetic isolate. Nutr Metab Cardiovasc Dis 2009; 19: 455-461.
20. GOULART AC, REXRODE KM, CHENG S, ROSE L, BURING JE, RIDKER PM, ZEE RY. Association of genetic variants with the metabolic syndrome in 20, 806 white women: The Women's Health Genome Study. Am Heart J 2009; 158: 257-262.
21. FALL T, INGELSSON E. Genome-wide association studies of obesity and metabolic syndrome. Mol Cell Endocrinol 2014; 382: 740-757.
22. EXPERT PANEL ON DETECTION, EVALUATION, AND TREATMENT OF HIGH BLOOD CHOLESTEROL IN ADULTS. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
23. GRUNDY SM, BREWER HB JR, CLEEMAN JI, SMITH SC JR, LENFANT C; AMERICAN HEART ASSOCIATION; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433-438.
24. MILAGRO FI, CAMPIÓN J, MARTÍNEZ JA. Weight gain induced by high-fat feeding involves increased liver oxidative stress. Obesity (Silver Spring) 2006; 14: 1118-1123.
25. ANDERSON EJ, LUSTIG ME, BOYLE KE, WOODLIEF TL, KANE DA, LIN CT, PRICE JW 3RD, KANG L, RABINOVITCH PS, SZETO HH, HOUMARD JA, CORTRIGHT RN, WASSERMAN DH, NEUFER PD. Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J Clin Invest 2009; 119: 573-581.
26. HENRIKSEN EJ, DIAMOND-STANIC MK, MARCHIONNE EM. Oxidative stress and the etiology of insulin resistance and type 2 diabetes. Free Radic Biol Med 2011; 51: 993-999.
27. JAMES AM, COLLINS Y, LOGAN A, MURPHY MP. Mitochondrial oxidative stress and the metabolic syndrome. Trends Endocrinol Metab 2012; 23: 429-434.
28. WHALEY-CONNELL A, MCCULLOUGH PA, SOWERS JR. The role of oxidative stress in the metabolic syndrome. Rev Cardiovasc Med 2011; 12: 21-29.
29. MARTINS AR, NACHBAR RT, GORJAO R, VINOLO MA, FESTUCCIA WT, LAMBERTUCCI RH, CURY-BOAVENTURA MF, SILVEIRA LR, CURI R, HIRABARA SM. Mechanisms underlying skeletal muscle insulin resistance induced by fatty acids: importance of the mitochondrial function. Lipids Health Dis 2012; 11: 30.
30. RODRIGUEZ-CUENCA S, COCHEMÉ HM, LOGAN A, ABAKUMOVA I, PRIME TA, ROSE C, VIDAL-PUIG A, SMITH AC, RUBINSZTEIN DC, FEARNLEY IM, JONES BA, POPE S, HEALES SJ, LAM BY, NEOGI SG, MCFARLANE I, JAMES AM, SMITH RA, MURPHY MP. Consequences of longterm oral administration of the mitochondria-targeted antioxidant MitoQ to wild-type mice. Free Radic Biol Med 2010; 48: 161-172.
31. MERCER JR, YU E, FIGG N, CHENG KK, PRIME TA, GRIFFIN JL, MASOODI M, VIDAL-PUIG A, MURPHY MP, BENNETT MR. The mitochondria-targeted antioxidant MitoQ decreases features of the metabolic syndrome in ATM+/-/ApoE-/- mice. Free Radic Biol Med 2012; 52: 841-849.
32. PATEL S, DOCAMPO R. In with the TRP channels: intracellular functions for TRPM1 and TRPM2. Sci Signal 2009; 2: pe69.
33. TAKAHASHI N, KOZAI D, KOBAYASHI R, EBERT M, MORI Y. Roles of TRPM2 in oxidative stress. Cell Calcium 2011; 50: 279-287.
34. COLSOUL B, VENNEKENS R, NILIUS B. Transient receptor potential cation channels in pancreatic βcells. Rev Physiol Biochem Pharmacol 2011; 161: 87-110.
35. QIAN F, HUANG P, MA L, KUZNETSOV A, TAMARINA N, PHILIPSON LH. TRP genes: candidates for nonselective cation channels and store-operated channels in insulin-secreting cells. Diabetes 2002; 51: S183-S189.
36. INAMURA K, SANO Y, MOCHIZUKI S, YOKOI H, MIYAKE A, NOZAWA K, KITADA C, MATSUSHIME H, FURUICHI K. Response to ADP-ribose by activation of TRPM2 in the CRI-G1 insulinoma cell line. J Membr Biol 2003; 191: 201-207.
37. TOGASHI K, HARA Y, TOMINAGA T, HIGASHI T, KONISHI Y, MORI Y, TOMINAGA M. TRPM2 activation by cyclic ADP-ribose at body temperature is involved in insulin secretion. EMBO J 2006; 25: 1804-1815.
38. UCHIDA K, DEZAKI K, DAMDINDORJ B, INADA H, SHIUCHI T, MORI Y, YADA T, MINOKOSHI Y, TOMINAGA M. Lack of TRPM2 impaired insulin secretion and glucose metabolisms in mice. Diabetes 2011; 60: 119-126.
39. MAJEED Y, BAHNASI Y, SEYMOUR VA, WILSON LA, MILLIGAN CJ, AGARWAL AK, SUKUMAR P, NAYLOR J, BEECH DJ. Rapid and contrasting effects of rosiglitazone on transient receptor potential TRPM3 and TRPC5 channels. Mol Pharmacol 2011; 79: 1023-1030.
40. WAGNER TF, LOCH S, LAMBERT S, STRAUB I, MANNEBACH S, MATHAR I, DÜFER M, LIS A, FLOCKERZI V, PHILIPP SE, OBERWINKLER J. Transient receptor potential M3 channels are ionotropic steroid receptors in pancreatic beta cells. Nat Cell Biol 2008; 10: 1421-1430.
41. COLSOUL B, SCHRAENEN A, LEMAIRE K, QUINTENS R, VAN LOMMEL L, SEGAL A, OWSIANIK G, TALAVERA K, VOETS T, MARGOLSKEE RF, KOKRASHVILI Z, GILON P, NILIUS B, SCHUIT FC, VENNEKENS R. Loss of high-frequency glucose-induced Ca2+ oscillations in pancreatic islets correlates with impaired glucose tolerance in Trpm5-/- mice. Proc Natl Acad Sci U S A 2010; 107: 5208-5213.
42. YOUNG RL, SUTHERLAND K, PEZOS N, BRIERLEY SM, HOROWITZ M, RAYNER CK, BLACKSHAW LA. Expression of taste molecules in the upper gastrointestinal tract in humans with and without type 2 diabetes. Gut 2009; 58: 337-346.
43. KETTERER C, MÜSSIG K, HENI M, DUDZIAK K, RANDRIANARISOA E, WAGNER R, MACHICAO F, STEFAN N, HOLST JJ, FRITSCHE A, HÄRING HU, STAIGER H. Genetic variation within the TRPM5 locus associates with prediabetic phenotypes in subjects at increased risk for type 2 diabetes. Metabolism 2011; 60: 1325-1333.
44. WATANABE H, MURAKAMI M, OHBA T, TAKAHASHI Y, ITO H. TRP channel and cardiovascular disease. Pharmacol Ther 2008; 118: 337-351.
45. GUINAMARD R, CHATELIER A, DEMION M, POTREAU D, PATRI S, RAHMATI M, BOIS P. Functional characterization of a Ca2+-activated non-selective cation channel in human atrial cardiomyocytes. J Physiol 2004; 558: 75-83.
46. LIU H, EL ZEIN L, KRUSE M, GUINAMARD R, BECKMANN A, BOZIO A, KURTBAY G, MÉGARBANÉ A, OHMERT I, BLAYSAT G, VILLAIN E, PONGS O, BOUVAGNET P. Gain-of-function mutations in TRPM4 cause autosomal dominant isolated cardiac conduction disease. Circ Cardiovasc Genet 2010; 3: 374-385.
47. DIETRICH A, MEDEROS Y SCHNITZLER M, GOLLASCH M, GROSS V, STORCH U, DUBROVSKA G, OBST M, YILDIRIM E, SALANOVA B, KALWA H, ESSIN K, PINKENBURG O, LUFT FC, GUDERMANN T, BIRNBAUMER L. Increased vascular smooth muscle contractility in TRPC6- /- mice. Mol Cell Biol 2005; 25: 6980-6989.
48. MATHAR I, VENNEKENS R, MEISSNER M, KEES F, VAN DER MIEREN G, CAMACHO LONDOÑO JE, UHL S, VOETS T, HUMMEL B, VAN DEN BERGH A, HERIJGERS P, NILIUS B, FLOCKERZI V, SCHWEDA F, FREICHEL M. Increased catecholamine secretion contributes to hypertension in TRPM4-deficient mice. J Clin Invest 2010; 120: 3267-3279.
49. TOUYZ RM, HE Y, MONTEZANO AC, YAO G, CHUBANOV V, GUDERMANN T, CALLERA GE. Differential regulation of transient receptor potential melastatin 6 and 7 cation channels by ANG II in vascular smooth muscle cells from spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 2006; 290: R73-R78.
50. HU G, OBOUKHOVA EA, KUMAR S, STUREK M, OBUKHOV AG. Canonical transient receptor potential channels expression is elevated in a porcine model of metabolic syndrome. Mol Endocrinol 2009; 23: 689-699.